EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation

Hannah C Kubinski, Hannah W Despres, Bryan A Johnson, Madaline M Schmidt, Sara A Jaffrani, Allyson H Turner, Conor D Fanuele, Margaret G Mills, Kumari G Lokugamage, Caroline M Dumas, David J Shirley, Leah K Estes and 12 more

PLOS Biology · 2025

DOI: 10.1371/journal.pbio.3003115 ↗

At a glance

Journal article in PLOS Biology, 2025. Written by Hannah C Kubinski and 23 co-authors. Institution: Department of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States…. Major MEDLINE topics: SARS-CoV-2, COVID-19, Coronavirus Nucleocapsid Proteins, Nucleocapsid. Cited 10 times so far (Crossref); 80 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIAID NIH HHS, NIGMS NIH HHS, American Lung Association.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The evolution of SARS-CoV-2 variants and their respective phenotypes represents an important set of tools to understand basic coronavirus biology as well as the public health implications of individual mutations in variants of concern. While mutations outside of spike are not well studied, the entire viral genome is undergoing evolutionary selection, with several variants containing mutations in the central disordered linker region of the nucleocapsid (N) protein. Here, we identify a mutation (G215C), characteristic of the Delta variant, that introduces a novel cysteine into this linker domain, which results in the formation of a more stable N-N dimer. Using reverse genetics, we determined that this cysteine residue is necessary and sufficient for stable dimer formation in a WA1 SARS-CoV-2 background, where it results in significantly increased viral growth both in vitro and in vivo. Mechanistically, we show that the N:G215C mutant has more encapsidation as measured by increased RNA binding to N, N incorporation into virions, and electron microscopy showing that individual virions are larger, with elongated morphologies.

Subjects

MeSH terms (MEDLINE)

SARS-CoV-2COVID-19Coronavirus Nucleocapsid ProteinsNucleocapsidViral Genome PackagingHumansAnimalsMutationGenome, ViralChlorocebus aethiopsVero CellsVirus AssemblyVirionPhosphoproteins

Substances

Coronavirus Nucleocapsid Proteinsnucleocapsid phosphoprotein, SARS-CoV-2Phosphoproteins

Authors and institutions

  • Department of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America.
  • Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Center for Tropical Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
  • Department of Biology, University of Vermont, Burlington, Vermont, United States of America.

ORCID profiles: Emily A Bruce

Funding

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • American Lung Association
  • George Mason University
  • National Institute of Allergy and Infectious Diseases
  • Burroughs Wellcome Fund
  • National Institute of General Medical Sciences
  • University of Vermont

Cite

APA

Kubinski, H. C., Despres, H. W., Johnson, B. A., Schmidt, M. M., Jaffrani, S. A., Turner, A. H., Fanuele, C. D., Mills, M. G., Lokugamage, K. G., Dumas, C. M., Shirley, D. J., Estes, L. K., Pekosz, A., Crothers, J. W., Roychoudhury, P., Greninger, A. L., Jerome, K. R., Di Genova, B. M., Walker, D. H., …, & Bruce, E. A. (2025). Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003115

Vancouver

Kubinski HC, Despres HW, Johnson BA, Schmidt MM, Jaffrani SA, Turner AH, et al. Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation. PLOS Biology. 2025. doi:10.1371/journal.pbio.3003115

BibTeX
@article{Kubinski2025,
  author = {Kubinski, Hannah C and Despres, Hannah W and Johnson, Bryan A and Schmidt, Madaline M and Jaffrani, Sara A and Turner, Allyson H and Fanuele, Conor D and Mills, Margaret G and Lokugamage, Kumari G and Dumas, Caroline M and Shirley, David J and Estes, Leah K and Pekosz, Andrew and Crothers, Jessica W and Roychoudhury, Pavitra and Greninger, Alexander L and Jerome, Keith R and Di Genova, Bruno Martorelli and Walker, David H and Ballif, Bryan A and Ladinsky, Mark S and Bjorkman, Pamela J and Menachery, Vineet D and Bruce, Emily A},
  title = {Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation},
  journal = {PLOS Biology},
  year = {2025},
  doi = {10.1371/journal.pbio.3003115}
}
Start for free →